Effect of drug rosuvastatin in females with type 2 diabetes mellitus
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2018/07/014844
- Lead Sponsor
- Sri Venkateswara Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 29
Newly diagnosed female patients with Type 2 Diabetes Mellitus aged between 40-70 years as per the revised ADA criteria (47):i.e
i) Fasting plasma glucose =126mg/dL (7.0mmol/L)
ii) 2 hour plasma glucose =200mg/dL (11.1mmol/L)
iii) Glycosylated hemoglobin (HbA1c) >6.5% (48 mmol/mol)
Patients with T2DM on oral antidiabetic treatment will be included.
Patients will be eligible of high intensity statin therapy as per ACC/AHA guidelines 2013 (48) i.e both
LDL Cholesterol >75 mg/dL and
A 10 year cardiovascular risk score = 7.5% on pooled cohort equation
Male patients with type 2 Diabetes mellitus
Patients with other forms of Diabetes (T1DM, Gestational diabetes mellitus)
Those on insulin therapy
Thyroid disorders not on treatment
Those on pioglitazone
Those on hormone replacement therapy
Liver and kidney diseases
Other inflammatory diseases
Acute illness
Malignancy
Alcoholics
Current smoking
On cholesterol lowering drugs
Pregnant and lactating women
Individuals who are not willing to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method